Organism 80617 - Bacillus subtilis (BACILLACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon2245
FamilyBACILLACEAE
GenusBACILLUS
SpeciesSUBTILIS
Species authority
SubspeciesSTRAIN TL-119
Subspecies authority
Comment
CitationSHOJI,J: HINOO,H: WAKISAKA,Y: KOIZUMI,K: MAYAMA,M:. (1975). STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. IV. ISOLATION OF A NEW PEPTIDE ANTIBIOTIC TL-119.. 28()
Geographical areaSOUTHEASTERN ASIA
CountryTHAILAND

Experiments

Filters
Worktypes (6)
9
9
9
9
3
3
No match
Pharmacology (3)
10
1
1
No match
12 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
320908
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIMYCOBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320909
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320910
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320911
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320912
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320913
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320914
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320915
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320916
CHEMICAL CONVERSION OFPHARMACOLOGY OF COMPOUND - IN VITROYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320917
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320918
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
320919
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
TOXIC EFFECT(GENERAL)
Bacillus subtilis (BACILLACEAE)
BACILLUS ANTIBIOTIC TL-119
Show SPARQL Queries (1)